Rwanda: Akagera Medicines Secures U.S.$1.5 Million to Improve Access to Vaccines

[New Times] Rwandan-owned Akagera Medicines and the Coalition for Epidemic Preparedness Innovations (CEPI) have entered a new partnership of $1.46 million (approx. Rwf1.83 billion) to improve vaccine delivery and accessibility in Africa.